Table 1 Baseline characteristics of the included study population
Patient characteristics | |
|---|---|
Total | 157 |
Age, median (IQR) | 75.3 (70.8–80.8) |
Male gender, n (%) | 103 (65.6) |
Caucasian origin, n (%) | 138 (89.0) |
Married/living together, n (%) | 94 (61.4) |
Higher Educational level, n (%) | 48 (30.6) |
Current smoking | 23 (15.0) |
Alcohol consumption | 77 (50.3) |
Disease specific | |
eGFR at study enrolment, mean (SD) | 16.2 (4.4) |
Δ eGFR (ml/min), mean (SD)a | 9.1 (8.0) |
Primairy kidney disease | |
Non-vascular cause, n (%) | 56 (35.7) |
Vascular cause, n (%) | 99 (63.1) |
Diabetes mellitus, n (%) | 63 (40.1) |
(history of) malignancy, n (%) | 47 (29.9) |
History of vascular disease, (n%) | 74 (47.4) |
Ankle-brachial index (right), mean (SD) | 0.96 (0.23) |
Medication use | |
Polypharmacy (the use of ≥5 medications), n (%) | 139 (89.7) |
Glucose lowering medication, n (%) | 54 (34.4) |
Antihypertensive medication, n (%) | 145 (92.4) |
Diuretics, n (%) | 94 (60.3) |
Cholesterol lowering drugs, n (%) | 112 (71.3) |
Vitamin D supplement, n (%) | 131 (83.4) |
Nutrition status | |
Normal Subjective Global Assessment (SGA) score | 42 (49.4) |
SNAQ score | |
Malnourished | 8 (10.7) |
Risk for malnutrition | 9 (12.0) |
BMI, median (IQR) | 27.4 (24.6–30.9) |
Special diet, n (%) | 127 (83.0) |
Geriatric assessment | |
Frail according to FFI, n (%) | 37 (24.5) |
Functional dependence by GARS-score, mean (IQR) | 26 (20.0–35.0) |
Dependent in IADL function, n (%) | 8 (5.0) |
Handgrip strength (kg), mean (SD) | |
Females | 17.2 (6.3) |
Males | 29.4 (8.1) |
Walking speed, mean (SD) (m/s) | 1.13 (0.98) |